Stopping Controversial Asthma Drugs Could Have Downside: Study – U.S. News & World Report

Stopping Controversial Asthma Drugs Could Have Downside: Study
U.S. News & World Report
The U.S. Food and Drug Administration has warned that asthma patients who take both long-acting beta-agonist and inhaled corticosteroid medications should be cautious about using them together once their condition is under control. Long-acting
Asthma Worsens with Step-Off TherapyMedPage Today
Study Questions Recommendation to Discontinue LABA Therapy in Asthma Science Daily (press release)

all 7 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.